SFLAP students are hard at work on one of the largest complex litigations in the country, a case with profound implications for public health. San Francisco’s case against major opioids manufacturers and distributors alleges that opioid producers orchestrated a widespread fraud that portrayed drugs like OxyContin and fentanyl as safe and effective, while at the same time opioid wholesalers failed to report massive quantities of suspicious sales. The lawsuit alleges that this deliberate deception created millions of addicts and led to hundreds of thousands of overdose deaths nationwide.
San Francisco was selected as one of the bellwether cases from among thousands of plaintiffs in the multi-district litigation. The case is slated go to trial in April 2022. SFALP students have been working on this case since its inception and will see it through trial and beyond.